The cost of unresectable stage III or stage IV melanoma in Italy

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Maio, Michele ^a   Ascierto, Paolo ^b   Testori, Alessandro ^c   Ridolfi, Ruggero ^d   Bajetta, Emilio ^e   Queirolo, Paola ^f   Guida, Michele ^g   Romanini, Antonella ^h   Chiarion Sileni, Vanna ⁱ   Pigozzo, Jacopo ⁱ   Di Giacomo, Anna Maria ^a   Calandriello, Mario ^j   Didoni, Guido ^j   Van Baardewijk, Marck ^k   Konto, Cyril ^l   Lucioni, Carlo ^m  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^e Istituto di Oncologia   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^h UNIVERSITY HOSPITAL OF PISA   (Italy)

ⁱ VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^j Health Outcome Research Unit   (Italy)

^k Novartis Oncology   (Netherlands)

^l BMS Global   (United Kingdom)

^m Springer Healthcare   (Italy)

more..

Author keywords

Clinical outcomes; Medical direct cost; Metastatic melanoma

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; OBSERVATIONAL STUDY; PRIORITY JOURNAL;

AGED; EUROPE; FEMALE; HEALTH CARE COSTS; HUMANS; ITALY; LONGITUDINAL STUDIES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SCANDINAVIA; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84868255082     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-91     Document Type: Article

References (25)

1. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997. Devries E, Bray I, Coebergh JW, et al. Int J Cancer 2003 107 119 126 10.1002/ijc.11360 12925966 (Pubitemid 37100095)
2. Estimates of the cancer incidence and mortality in Europe in 2006. Ferlay J, Autier P, Boniol M, et al. Ann Oncol 2007 18 581 592 17287242 (Pubitemid 46359643)
3. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Lens MB, Dawes M, Br J Dermatology 2004 150 179 185 10.1111/j.1365-2133.2004.05708.x (Pubitemid 38352453)
4. Epidemiology and clinical and pathologic characteristics of cutaneous malignant melanoma in Abruzzo (Italy). Amerio P, et al. Int J Dermatol 2009 48 7 718 722 10.1111/j.1365-4632.2009.03974.x 19570077
5. Melanoma. Miller AJ, Mihm MC, N Engl J Med 2006 355 51 65 10.1056/NEJMra052166 16822996
6. Cutaneous melanoma. Thompson JF, Scolyer RA, Kefford RF, Lancet 2005 365 687 701 15721476 (Pubitemid 40260892)
7. Management of cutaneous melanoma. Tsao H, Atkins MB, Sober AJ, N Engl J Med 2004 351 998 1012 10.1056/NEJMra041245 15342808 (Pubitemid 39166263)
8. Phase II study of E7070 in patients with metastatic melanoma. Smyth JF, Aamdal S, Awada A, et al. Ann Oncol 2005 16 158 161 10.1093/annonc/mdi016 15598954 (Pubitemid 40124494)
9. Reaching first base in the treatment of metastatic melanoma. Eggermont AMM, J Clin Oncol 2006 24 4673 4674 10.1200/JCO.2006.07.3593 16966683 (Pubitemid 46630929)
10. U.K. guidelines for the management of cutaneous melanoma. Br J. Roberts DLL, Anstey AV, Barlow RJ, et al. Dermatology 2002 146 7 17 (Pubitemid 34158403)
11. Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center. Fabi A, Felici A, Metro G, et al. J Exp Clin Cancer Res 2011 30 10 10.1186/1756-9966-30-10 21244695
12. Final version of the american joint committee on cancer staging system for cutaneous melanoma. Balch CM, Buzaid AC, Soong SJ, et al. J Clin Oncol 2001 19 3635 3648 11504745 (Pubitemid 32786276)
13. Ministero dell'Economia e Finanze, Libro verde sulla Spesa Pubblica Roma 2007
14. Ministero della Salute, Hospice in Italia: prima rilevazione ufficiale, 2006 Medica Editoria e Diffusione Scientifica, Milano 2007
15. Ministero della Salute. Progetto Mattoni SSN. Pronto Soccorso e Sistema 118, Proposta metodologica per la valutazione dei costi dell'emergenza Roma 2007
16. Ministero della Sanità Prestazioni di assistenza ambulatoriale erogabili nell'ambito del Servizio Sanitario Nazionale e relative Decreto Ministeriale, Roma 1996
17. Banca Dati Sanitaria Farmaceutica VDA Net 2010 http://www.giofil.it (accessed Apr 19, 2011)
18. Conferenza delle Regioni e delle Province autonome, Tariffa unica convenzionale (TUC) per le prestazioni di assistenza ospedaliera. Regole e tariffe valide per l'anno 2009 Roma 2010
19. Surgery and radiotherapy in the treatment of cutaneous melanoma. Testori A, Rutkowski P, Marsden J, et al. Ann Oncol 2009 20 Suppl 6 vi22 vi29 10.1093/annonc/mdp257 19617294
20. Presidenza del Consiglio dei Ministri, Conferenza Stato Regioni Seduta del 24 luglio 2003
21. Descriptive study of the costs of diagnosis and treatment of cutaneous melanoma. Almazàn-Fernàndez FM, Serrano-Ortega S, Moreno-Villalonga JJ, Actas Dermosifiliogr 2009 100 785 791 10.1016/S0001- 7310(09)72552-9 19889300
22. The economic burden of melanoma in France: assessing healthcare use in a hospital setting. Chevalier J, Bonastre J, Avril M-F, Melanoma Res 2008 18 1 40 46 10.1097/CMR.0b013e3282f36203 18227707 (Pubitemid 351628055)
23. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. Stang A, Stausberg J, Boedeker W, Kerek-Bodden H, Jöckel K-H, JEADV 2008 22 65 72 18181975
24. Societal cost of skin cancer in Sweden 2005. Tinghög G, Carlsson P, Synnerstad I, Rosdhal I, Acta Dermo Venereol 2008 88 467 473 10.2340/00015555-0523
25. Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies. Cashin RP, Lui P, Machado M, Hemels MEH, Corey-Lisle PK, Einarson TR, Value Health 2008 11 2 259 271 10.1111/j.1524-4733. 2007.00243.x 18380638 (Pubitemid 351473617)